Apricus Biosciences

Apricus Biosciences, Inc.
Company typePublic
NasdaqAPRI
IndustryBiopharmaceutical
Founded1987
HeadquartersSan Diego, California, United States
Key people
Richard Pascoe
(CEO)
Brian Dorsey
(iSVP & Chief Development Officer) Barbara Troupin, MD, MBA (SVP & Chief Medical Officer)
ProductsVitaros, Fispemifene, RayVa, Femprox
RevenueUS$ 7.4 million (First Nine Months 2014)
Number of employees
120 (2012)
Website[1]

Apricus Biosciences, Inc. is a San Diego–based biopharmaceutical company advancing innovative medicines in urology and rheumatology.

Apricus Biosciences' first product, Vitaros®, has been approved in Europe and Canada for the treatment of erectile dysfunction[1] Other compounds in development include: low testosterone, rheumatology, sexual dysfunction, pain,[2]

  1. ^ Bujdos, Brian (16 November 2010). "New Topical Erectile Dysfunction Drug Vitaros Approved in Canada; Approved Topical Drug Testim Proves Helpful for Erectile Dysfunction". Archived from the original on 13 May 2011. Retrieved 7 April 2011.
  2. ^ "Apricus SEC Report". SEC. Retrieved 6 April 2011.